#nash and cancer

Collection of nash and cancer news, found 7 news.

Terns Pharmaceuticals appoints Ankang Li, Ph.D., J.D., CFA as Chief Financial Officer

Terns Pharmaceuticals appoints Ankang Li, Ph.D., J.D., CFA as Chief Financial Officer

  • 1st July 2019

- Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative ...

Terns Pharmaceuticals announces exclusive licensing and collaboration agreement with GENFIT to develop and commercialize elafibranor in the Greater China region

Terns Pharmaceuticals announces exclusive licensing and collaboration agreement with GENFIT to develop and commercialize elafibranor in the Greater China region

  • 25th June 2019

- Terns Pharmaceuticals, Inc. today announced an exclusive licensing and collaboration agreement with GENFIT (GNFT), a ...

Terns Pharmaceuticals initiates a Phase 1 clinical trial of TERN-101

Terns Pharmaceuticals initiates a Phase 1 clinical trial of TERN-101

  • 13th June 2019

- Terns Pharmaceuticals, Inc. today announced the initiation of a Phase 1 clinical trial of TERN-101, an farnesoid X ...

Terns Pharmaceuticals to present at BioCentury’s 26th Annual Future Leaders in Biotech Industry Conference

Terns Pharmaceuticals to present at BioCentury’s 26th Annual Future Leaders in Biotech Industry Conference

  • 8th April 2019

- Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly ...

Terns Pharmaceuticals to present preclinical data on two lead programs at the European Association for the Study of the Liver (EASL) Annual Meeting 2019

Terns Pharmaceuticals to present preclinical data on two lead programs at the European Association for the Study of the Liver (EASL) Annual Meeting 2019

  • 2nd April 2019

- Terns Pharmaceuticals, Inc. today announced presentation of preclinical data on its two lead programs at The ...

Terns Pharmaceuticals announces the appointment of Erin Quirk, M.D., as Chief Medical Officer

Terns Pharmaceuticals announces the appointment of Erin Quirk, M.D., as Chief Medical Officer

  • 17th January 2019

- Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly ...

Terns Pharmaceuticals completes $80 million series B financing to advance pipeline of drugs to treat NASH and cancer

Terns Pharmaceuticals completes $80 million series B financing to advance pipeline of drugs to treat NASH and cancer

  • 31st October 2018

- Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly ...